13,866 Shares in Teleflex Incorporated (NYSE:TFX) Bought by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. purchased a new position in Teleflex Incorporated (NYSE:TFX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 13,866 shares of the medical technology company's stock, valued at approximately $2,471,000.

Several other institutional investors also recently bought and sold shares of TFX. Headlands Technologies LLC bought a new position in shares of Teleflex in the fourth quarter worth approximately $29,000. Avior Wealth Management LLC raised its holdings in Teleflex by 81.2% in the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after acquiring an additional 125 shares during the last quarter. IFP Advisors Inc lifted its position in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after acquiring an additional 217 shares in the last quarter. Exchange Traded Concepts LLC boosted its stake in Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after purchasing an additional 94 shares during the last quarter. Finally, R Squared Ltd bought a new stake in shares of Teleflex in the 4th quarter worth $64,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Stock Performance

TFX traded down $2.00 during trading on Tuesday, hitting $130.09. The company's stock had a trading volume of 44,666 shares, compared to its average volume of 615,014. The business's 50 day simple moving average is $147.12 and its 200-day simple moving average is $180.28. The firm has a market cap of $6.03 billion, a PE ratio of 25.86, a P/E/G ratio of 1.73 and a beta of 1.19. Teleflex Incorporated has a one year low of $124.66 and a one year high of $249.91. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping analysts' consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million for the quarter, compared to analysts' expectations of $813.24 million. As a group, sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.05%. The ex-dividend date was Friday, March 7th. Teleflex's dividend payout ratio is 95.77%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on TFX. Piper Sandler reaffirmed a "neutral" rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Morgan Stanley lowered their target price on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 5th. Wells Fargo & Company reduced their price target on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Bank of America downgraded shares of Teleflex from a "neutral" rating to an "underperform" rating and lowered their price objective for the company from $235.00 to $140.00 in a research report on Tuesday, March 4th. Finally, StockNews.com downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $181.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.